1887

Journal of Medical Microbiology logo

Volume 62, Issue 9

A 10 year surveillance for antimicrobial susceptibility of and in community- and hospital-associated intra-abdominal infections in China Free

Abstract

The objective of this study was to investigate the susceptibility of hospital-associated (HA) and community-associated (CA) and isolated from patients with intra-abdominal infections (IAIs) in China. From 2002 to 2011, the minimum inhibitory concentrations (MICs) of 12 antibiotics against 3074 and 1025 from 23 centres located in 16 cities were determined by the broth microdilution method. During the 10 year study period, ertapenem, imipenem, amikacin and piperacillin-tazobactam retained high and stable activity against and isolates regardless of whether their source was HA or CA and regardless of their extended-spectrum beta-lactamase (ESBL) production. However, the susceptibility of to cephalosporins and ampicillin-sulbactam decreased dramatically during the 10 years, especially for the CA isolates. Fluoroquinolones showed low activity against . During the whole study period, the ESBL rates for isolates from IAIs increased from 36.1 % in 2002–2003 to 68.1 % in 2010–2011 (<0.001). Correspondingly, the ESBL rates in HA isolates increased from 52.2 % in 2002–2003 to 70.0 % in 2010–2011 ( = 0.001), and in CA isolates from 19.1 % in 2002–2003 to 61.6 % in 2010–2011 (<0.001). The ESBL-positive rate in remained between 30.1 and 39.3 % of the total isolates with no significant change during the 10 years. In conclusion, carbapenems retained the highest susceptibility rates against HA and CA and . High prevalence of ESBL in HA and fast-growing resistance in CA severely limit the empirical use of the third- and fourth-generation cephalosporins in the therapy of IAIs.

  • Received:
  • Accepted:
  • Published Online:
© 2013 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.059816-0
2013-09-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/9/1343.html?itemId=/content/journal/jmm/10.1099/jmm.0.059816-0&mimeType=html&fmt=ahah

References

  1. Baquero F., Hsueh P. R., Paterson D. L., Rossi F., Bochicchio G. V., Gallagher G., Lantz K., Villasenor J. B., McCarroll K. other authors 2009; In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect (Larchmt) 10:99–104 [View Article][PubMed]
     [Google Scholar]
  2. Ben-Ami R., Rodríguez-Baño J., Arslan H., Pitout J. D., Quentin C., Calbo E. S., Azap O. K., Arpin C., Pascual A. other authors 2009; A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49:682–690 [View Article][PubMed]
     [Google Scholar]
  3. Chanawong A., M’Zali F. H., Heritage J., Xiong J. H., Hawkey P. M. 2002; Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People’s Republic of China. Antimicrob Agents Chemother 46:630–637 [View Article][PubMed]
     [Google Scholar]
  4. CLSI 2012; Method for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 9th edn, M7-A9. Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  5. CLSI 2013; Performance Standards for Antimicrobial Susceptibility Testing. 23rd Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  6. Dias V. C., da Silva V. L., Firmo E. O., Bastos L. Q., Bastos A. N., Bastos R. V., Diniz C. G. 2012; Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period. J Chemother 24:178–181 [View Article][PubMed]
     [Google Scholar]
  7. Essack S. Y. 2000; Treatment options for extended-spectrum beta-lactamase-producers. FEMS Microbiol Lett 190:181–184[PubMed]
     [Google Scholar]
  8. Guembe M., Cercenado E., Alcalá L., Marín M., Insa R., Bouza E. 2008; Evolution of antimicrobial susceptibility patterns of aerobic and facultative Gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. Rev Esp Quimioter 21:166–173[PubMed]
     [Google Scholar]
  9. Hawser S. P., Bouchillon S. K., Hoban D. J., Badal R. E. 2009a; In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. Int J Antimicrob Agents 34:585–588 [View Article][PubMed]
     [Google Scholar]
  10. Hawser S. P., Bouchillon S. K., Hoban D. J., Badal R. E., Hsueh P. R., Paterson D. L. 2009b; Emergence of high levels of extended-spectrum-β-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 53:3280–3284 [View Article][PubMed]
     [Google Scholar]
  11. Hoban D. J., Bouchillon S. K., Hawser S. P., Badal R. E. 2010; Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn Microbiol Infect Dis 66:78–86 [View Article][PubMed]
     [Google Scholar]
  12. Ko W. C., Hsueh P. R. 2009; Increasing extended-spectrum β-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the SMART Study 2002-2006. J Infect 59:95–103 [View Article][PubMed]
     [Google Scholar]
  13. Livermore D. M., Oakton K. J., Carter M. W., Warner M. 2001; Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases. Antimicrob Agents Chemother 45:2831–2837 [View Article][PubMed]
     [Google Scholar]
  14. Nicoletti G., Nicolosi D., Rossolini G. M., Stefani S. 2009; Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance. J Chemother 21:Suppl 15–11[PubMed] [CrossRef]
     [Google Scholar]
  15. Park S. H., Byun J. H., Choi S. M., Lee D. G., Kim S. H., Kwon J. C., Park C., Choi J. H., Yoo J. H. 2012; Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 12:149 [View Article][PubMed]
     [Google Scholar]
  16. Paterson D. L. 2000; Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 6:460–463 [View Article][PubMed]
     [Google Scholar]
  17. Pitout J. D., Nordmann P., Laupland K. B., Poirel L. 2005; Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56:52–59 [View Article][PubMed]
     [Google Scholar]
  18. Rossi F., Baquero F., Hsueh P. R., Paterson D. L., Bochicchio G. V., Snyder T. A., Satishchandran V., McCarroll K., DiNubile M. J., Chow J. W. 2006; In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 58:205–210 [View Article][PubMed]
     [Google Scholar]
  19. Sun Y., Zeng Z., Chen S., Ma J., He L., Liu Y., Deng Y., Lei T., Zhao J., Liu J. H. 2010; High prevalence of bla CTX-M extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 16:1475–1481 [View Article][PubMed]
     [Google Scholar]
  20. Tian S. F., Chu Y. Z., Chen B. Y., Nian H., Shang H. 2011; ISEcp1 element in association with bla CTX-M genes of E. coli that produce extended-spectrum β-lactamase among the elderly in community settings. Enferm Infecc Microbiol Clin 29:731–734 [View Article][PubMed]
     [Google Scholar]
  21. Wang H., Dzink-Fox J. L., Chen M., Levy S. B. 2001; Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother 45:1515–1521 [View Article][PubMed]
     [Google Scholar]
  22. Wang H., Kelkar S., Wu W., Chen M., Quinn J. P. 2003; Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob Agents Chemother 47:790–793 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.059816-0
Loading
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China
J. Med. Microbiol. 62, 1343 (2013); https://doi.org/10.1099/jmm.0.059816-0
/content/journal/jmm/10.1099/jmm.0.059816-0
/content/journal/jmm/10.1099/jmm.0.059816-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error